Clinical Trial Update: HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized Trial [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating HAIC plus toripalimab versus HAIC plus sorafenib in hepatocellular carcinoma with portal vein tumor thrombosis (PVTT); non-comparative,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Sorafenib (Sorafenib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN